Dirk Hofmann is a seasoned professional in the biopharmaceutical industry, currently serving as the Global Pandemic Franchise Lead for Governments at Seqirus since July 2015. With a career spanning over three decades, Dirk has held significant positions at leading companies, including Novartis and Syngenta Biopharma, where expertise in global development and government contracts was developed. Notable achievements include the addition of six products to a portfolio at Syngenta Biopharma and leading pandemic influenza development efforts at Novartis and Seqirus. Dirk began a career in research at Ciba-Geigy AG and has an extensive academic background, having earned a PhD in Microbiology/Biochemistry from the German Governmental Research Institute for Biotechnology and a degree in Pharmacy from Technical University Braunschweig.
This person is not in any teams
This person is not in any offices